<?xml version="1.0" encoding="UTF-8"?>
<ref id="B5-antibiotics-10-00141">
 <label>5.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fiore</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Alfieri</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>di Franco</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Pace</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Simeon</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Ingoglia</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Cortegiani</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-Analysis</article-title>
  <source>Antibiotics</source>
  <year>2020</year>
  <volume>9</volume>
  <elocation-id>388</elocation-id>
  <pub-id pub-id-type="doi">10.3390/antibiotics9070388</pub-id>
  <?supplied-pmid 32645986?>
  <pub-id pub-id-type="pmid">32645986</pub-id>
 </element-citation>
</ref>
